EUVIMEDEUVIMED entdecken
Crossref

Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease

K. Nsiah, V.P. Dzogbefia, D. Ansong, A. Osei Akoto, H. Boateng, D. Ocloo

Clinical medicine. Blood disorders · 2011-01 · 4 · CMBD.S3969

DOI: 10.4137/cmbd.s3969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical medicine. Blood disorders, online erschienen am 12.04.2011. Verfasst von K. Nsiah und 5 weiteren Autor:innen. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated aminotransferase levels are commonly associated with compromised hepatic integrity from various insults. In sickle cell disease, aspartate transaminase (AST) is also released via intravascular hemolysis. This study was done to determine the pattern of changes in AST and alanine transaminase (ALT), in particular the AST:ALT ratio, and to relate these to the hemolytic state, which we consider to be more important than hepatic and cardiac dysfunction in some individuals with sickle cell disease.

Methods

Serum aminotransferase levels were measured in 330 subjects with sickle cell disease, as well as hemoglobin, reticulocytes, and lactate dehydrogenase. The AST:ALT ratio was designated as a hemolytic marker, and simple and multivariate regression analyses were carried out between this ratio and other hemolytic markers.

Results

Mean AST and ALT levels were 48.24 % 27.78 and 26.48 % 22.73 U/L, respectively. However, for 49 subjects without sickle cell disease, mean AST and ALT levels were the same, ie, 23.0 U/L. In the subjects with sickle cell disease, the increases in AST levels were far higher than for ALT, supporting its release via intravascular hemolysis. In 95.8% of the subjects with sickle cell disease, the AST:ALT ratio was > 1, but our results did not suggest overt malfunctioning of the liver and heart in the majority of subjects.

Conclusion

Regression analyses support the use of the AST:ALT ratio as a hemolytic marker, because it has an inverse association with the hemoglobin level. Whether in steady state or in crisis, provided hepatic and cardiac integrity has not been compromised, subjects with sickle cell disease would have higher AST levels due to the hemolytic nature of the condition. This is the first report highlighting the AST:ALT ratio in sickle cell disease.

Zitieren

APA

Nsiah, K., Dzogbefia, V., Ansong, D., Akoto, A. O., Boateng, H., & Ocloo, D. (2011). Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease. Clinical medicine. Blood disorders, 4, CMBD.S3969. https://doi.org/10.4137/cmbd.s3969

Vancouver

Nsiah K, Dzogbefia V, Ansong D, Akoto AO, Boateng H, Ocloo D. Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease. Clinical medicine. Blood disorders. 2011;4:CMBD.S3969. doi:10.4137/cmbd.s3969

BibTeX
@article{Nsiah2011,
  author = {Nsiah, K. and Dzogbefia, V.P. and Ansong, D. and Akoto, A. Osei and Boateng, H. and Ocloo, D.},
  title = {Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease},
  journal = {Clinical medicine. Blood disorders},
  year = {2011},
  volume = {4},
  pages = {CMBD.S3969},
  doi = {10.4137/cmbd.s3969}
}
Kostenlos starten →